| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/10/2006 | DE60115222T2 Kombination von defibrotid und g-csf und ihre verwendung zur aktivierung hämatopoietischer vorläuferzellen Progenitor cell combination of defibrotide and g-csf and their use for the activation of hematopoietic |
| 08/10/2006 | DE60024843T2 Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten Containing vaccines for oral use the liposome and a nucleic acid |
| 08/10/2006 | DE112004001553T5 Verpflanzungsmaterialien, die bioaktive Substanzen enthalten, und Methoden zu deren Herstellung Transplant materials containing bioactive substances, and methods for their preparation |
| 08/10/2006 | DE102005004752A1 Pharmazeutischer Wirkstoff zur Behandlung von Multipler Sklerose und AIDS A pharmaceutical agent for the treatment of multiple sclerosis and AIDS |
| 08/10/2006 | CA2596686A1 Preventive or therapeutic agent for herpesvirus-related disease |
| 08/10/2006 | CA2596189A1 Dosage forms of active ingredients containing hydroxystilbene for treating menopausal complaints |
| 08/10/2006 | CA2596178A1 Method for producing a drug extract that contains hydroxystilbene |
| 08/10/2006 | CA2595786A1 Compositions and methods for treating fibrotic disorders |
| 08/09/2006 | EP1688481A1 Bifidobacterium in the treatment of inflammatory disease |
| 08/09/2006 | EP1688437A1 Antibody composition specifically binding to il-5 receptor |
| 08/09/2006 | EP1688430A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2006 | EP1688425A2 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 08/09/2006 | EP1688420A1 5-5-membered fused heterocyclic compound and use thereof as hcv polymerase inhibitor |
| 08/09/2006 | EP1688419A1 Novel compound and medicinal composition |
| 08/09/2006 | EP1688418A2 Chemokine receptor antagonists and methods of use thereof |
| 08/09/2006 | EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |
| 08/09/2006 | EP1688412A2 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 08/09/2006 | EP1688410A1 Crystal of phenylalanine derivative and process for producing the same |
| 08/09/2006 | EP1688156A2 A filtrate composition for use in dialysis via the colon |
| 08/09/2006 | EP1688149A1 Paste formulations comprising silica |
| 08/09/2006 | EP1688144A1 Ophthalmic compositions containing quinolone-antibiotics |
| 08/09/2006 | EP1688142A1 Terfenadine carboxylate and the treatment of dermal irritation |
| 08/09/2006 | EP1688138A1 Receptor function regulating agent |
| 08/09/2006 | EP1688134A2 Dry powder inhaler for transpulmonary administration |
| 08/09/2006 | EP1688133A1 Freeze-dried composition for transpulmonary administration |
| 08/09/2006 | EP1687006A1 Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients |
| 08/09/2006 | EP1686979A2 Activation of hypoxia-inducible gene expression |
| 08/09/2006 | EP1472249B1 Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments |
| 08/09/2006 | EP1458387B1 Orodispersible tablets containing fexofenadine |
| 08/09/2006 | EP1455779B1 Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 08/09/2006 | EP1453949B1 Production of cell suspensions |
| 08/09/2006 | EP1453832B1 Ring fused pyrazole derivatives |
| 08/09/2006 | EP1448179B1 Substituted bicyclo 3.3.1 nonan-2,4,9-triones as pharmaceutical active ingredients |
| 08/09/2006 | EP1441737B1 Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity |
| 08/09/2006 | EP1399442B1 Cak inhibitors and uses thereof |
| 08/09/2006 | EP1397361B1 Carboline derivatives as pdev inhibitors |
| 08/09/2006 | EP1383483A4 Controlled delivery of tetracycline compounds and tetracycline derivatives |
| 08/09/2006 | EP1363637B1 Pyrimidine compounds and methods for their preparation |
| 08/09/2006 | EP1354032B1 Gene regulation therapy involving ferritin |
| 08/09/2006 | EP1329456B1 Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same |
| 08/09/2006 | EP1317453B1 Isoxazoles and their use as inhibitors of erk |
| 08/09/2006 | EP1246623B1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof |
| 08/09/2006 | EP1187613B1 Amide substituted imidazoquinolines |
| 08/09/2006 | EP1165099B1 Angiotensin ii and analogs thereof for limiting scar and adhesion formation |
| 08/09/2006 | EP1148881B1 USE OF PYRIDAZINO ¬4,5-(b)|-INDOLE-1-ACETAMIDE DERIVATIVES FOR PREPARING MEDICINES FOR TREATING DISEASES RELATED TO THE DYSFUNCTION OF PERIPHERAL BENZODIAZEPIN RECEPTORS |
| 08/09/2006 | EP1144003B1 Methods and devices for delivery of agents to breast milk ducts |
| 08/09/2006 | EP1143981B1 Use of n-glycolneuraminic acid and its derivatives for the manufacture of a medicament for the treatment of hiv infections |
| 08/09/2006 | EP1135135A4 Chk1 kinase inhibitors |
| 08/09/2006 | EP1083873B1 Heterocyclic thioester and ketone hair growth compositions and uses |
| 08/09/2006 | EP1076553B1 Pharmaceutical, hygienic and/or cosmetic compositions containing sea water and uses |
| 08/09/2006 | EP1033979B1 Combination of cyp2a enzyme inhibitors and nicotine and their therapeutic use |
| 08/09/2006 | EP1032393B1 Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 08/09/2006 | EP0988316B1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 08/09/2006 | EP0988301B1 Imidazolyl-cyclic acetals |
| 08/09/2006 | EP0951472B1 Peptide compositions with growth factor-like activity |
| 08/09/2006 | EP0935656B1 Hedgehog interacting proteins and uses related thereto |
| 08/09/2006 | CN1816551A Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
| 08/09/2006 | CN1816536A Regulator of cannabinoid receptor |
| 08/09/2006 | CN1816353A Medicinal composition for preventing or treating Th1 type immunological disease |
| 08/09/2006 | CN1816345A Preventive and/or remedy for diseases accompanied by tissue destruction |
| 08/09/2006 | CN1816333A Staurosporine derivatives for hypereosinophilic syndrome |
| 08/09/2006 | CN1814295A Method for preparing gene therapeutic tissue engineering stent |
| 08/09/2006 | CN1814277A Use of methionine enkephalin in preparation of medicine for reducing toxic and side effect of chemical or radioactive therapy |
| 08/09/2006 | CN1814271A Chinese medicine vemedy for treating globus hysteritis and preparing method |
| 08/09/2006 | CN1814190A Black-white drinking liquor for treating night sweat |
| 08/09/2006 | CN1813911A Liquid capsule for treating discomfort caused by heatstroke and its preparing method |
| 08/09/2006 | CN1813890A Liquid capsule for treating heat-wet cold and vomit-diarrhoea and its preparing method |
| 08/09/2006 | CN1813868A Composition for treating and improving chronic fatigue syndrome and its preparing method |
| 08/09/2006 | CN1813858A Method for preparing oral liquid of several micron powders for reducing blood sugar and anti-fatigue |
| 08/09/2006 | CN1813857A Method for preparing particle, capsule and tablet of several miccron powders for reducing blood sugar and anti-fatigue |
| 08/09/2006 | CN1813782A Composition of ginkgo leaf extract and dipyridamole, medicine containing same and preparing method thereof |
| 08/09/2006 | CN1813723A Application of gaba-receptor modulators for the preventing/or treatment of neurodegenerative diseases of the eye |
| 08/09/2006 | CN1813699A Medicinal composition |
| 08/09/2006 | CN1813559A Composition for regulating animal growth, method of manufacture and use thereof |
| 08/09/2006 | CN1268753C Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/09/2006 | CN1268743C genetic construct for coding cell targeting part and heterologous precursor activating enzyme, and its application |
| 08/09/2006 | CN1268741C Therapy for 'alpha'-galactosidase deficiency |
| 08/09/2006 | CN1268637C I (chlamydia) protein, gene sequence and uses thereof |
| 08/09/2006 | CN1268626C Dihydro-benzo(b)(1,4)diazepin-2-one derivatives as mglur2 antagonists I |
| 08/09/2006 | CN1268625C Cyclic amp-specific phosphodiesterase inhibitors |
| 08/09/2006 | CN1268624C A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidine-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride |
| 08/09/2006 | CN1268622C New ramification of diterpenes possessing periodic inhibitory action like matricyte of sea star egg |
| 08/09/2006 | CN1268618C 1,5-benzothiazepines compounds and its use as antilipemic agent |
| 08/09/2006 | CN1268610C Sulfonamide derivatives |
| 08/09/2006 | CN1268600C Method for the nitration of phenolic compounds |
| 08/09/2006 | CN1268351C Sugar absorption inhibitors and process for producing the same |
| 08/09/2006 | CN1268345C Method of treating hepatitis delta viral infection |
| 08/09/2006 | CN1268340C Pharmaceutical composition comprising condensed indole compound |
| 08/09/2006 | CN1268336C Pharmaceutical composition, dosage form, and method of epothilones for oral administration |
| 08/09/2006 | CN1268334C Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 08/09/2006 | CN1268333C Indolinone compounds for the treatment of disease |
| 08/09/2006 | CN1268323C Rhodiola sacra soft capsule and its preparation |
| 08/09/2006 | CN1268319C Rhodiola sacra injection and its preparation |
| 08/08/2006 | US7087776 Silanol enzyme inhibitors |
| 08/08/2006 | US7087758 Quinoline inhibitors of hyaki and hyak3 kinases |
| 08/08/2006 | US7087756 6-(4-Dimethylaminomethyl-phenyl)-3-phenyl-5H-isoxazolo[4,5-c]pyridine-4-one and 6-[4-(2-Methoxy-ethoxymethyl)-phenyl]-5-methyl-3-phenyl-5H-isoxazolo[4,5-c]pyridin-4-one; use treating Parkinson's disease |
| 08/08/2006 | US7087743 Bleaching; skin disorders; genetic engineered nucleic acid; topical applying |
| 08/08/2006 | US7087716 Regulator of G protein signalling |
| 08/08/2006 | US7087661 Safe and effective biofilm inhibitory compounds and health-related uses thereof |
| 08/08/2006 | US7087648 Methods for modulating macrophage proliferation using polyamine analogs |